Voisard Asset Management Group »

Miragen Therapeutics shares owned by Voisard Asset Management Group

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Voisard Asset Management Group from 13F filings

Historical chart of Voisard Asset Management Group investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Voisard Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Voisard Asset Management Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.3k 100 22.75
2024-06-30 $1.3k 100 13.01
2024-03-31 $1.8k 100 17.51
2023-12-31 $2.2k 100 21.78

More positions owned by Voisard Asset Management Group

J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Ishares Tr Core Us Aggbd Et (AGG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Core S&p U.s. Growth ETFs (IUSG)

View all positions for Voisard Asset Management Group

Top funds holding Miragen Therapeutics

BlackRock
BlackRock
Deep Track Capital
VR Adviser
Fairmount Funds Management
Vanguard Group
Paradigm Biocapital Advisors
Perceptive Advisors
State Street Corporation
Commodore Capital
Novo A/S
Tang Capital Management
Alliancebernstein
Maverick Capital
Driehaus Capital Management

View all funds holding Miragen Therapeutics